From the Departments of Neurology (C.W., W.Z., M.R., Q.M., H.S., R.M.), Neurosurgery (C.L., F.Y., X.J.), and Emergency (S.L.), Xuanwu Hospital Capital Medical University, Beijing; Department of Neurology (N.X., Y. Lian, X.C., L. Zhang), The First Affiliated Hospital of Zhengzhou University; Department of Neurology (L. Zhou), Luzhou People's Hospital; Department of Neurology (X.X.), Zigong First People's Hospital; Department of Neurology (Y. Liang), Xiangtan Central Hospital; and Department of Neurology (L.W.), Guizhou Provincial People's Hospital, China.
Neurology. 2018 Apr 10;90(15):e1283-e1290. doi: 10.1212/WNL.0000000000005298. Epub 2018 Mar 14.
To investigate whether the plasma level of trimethylamine -oxide (TMAO), a proatherosclerotic intestinal microbiota metabolite, can be a predictor of ischemic brain injury secondary to carotid artery stenting (CAS).
In this multicenter, prospective cohort study, we enrolled patients with severe carotid artery stenosis (>70%) who were prepared for CAS. Plasma TMAO level was measured within 3 days before CAS, and MRI was performed 1 to 3 days after CAS.
The mean age of the 268 eligible patients was 64.4 years. New lesions on diffusion-weighted imaging (DWI) were detected in 117 patients (43.7%). TMAO level was higher in patients with new (DWI) lesions than in patients without new lesions (median 5.2 vs 3.2 µmol/L; < 0.001). Increased plasma TMAO levels were associated with an increased risk of having new lesions on DWI after CAS (adjusted odds ratio for the highest vs lowest quartile, 3.85; 95% confidence interval, 1.37-7.56, < 0.001; adjusted odds ratio for the third vs lowest quartile, 1.86; 95% confidence interval, 1.09-4.66, = 0.02). The area under the receiver operating characteristic curve of TMAO was 0.706 for new lesions on DWI, and the optimal cutoff value was 4.29 µmol/L. The sensitivity, specificity, positive predictive value, and negative predictive value of TMAO levels ≥4.29 µmol/L for predicting new lesions on DWI were 61.5%, 74.8%, 65.5%, and 65.5%, respectively.
Increased TMAO levels are associated with an increased risk of new ischemic brain lesions on post-CAS MRI scans.
探讨肠道菌群代谢产物三甲胺氧化物(trimethylamine -oxide,TMAO)能否预测颈动脉支架置入术(carotid artery stenting,CAS)后缺血性脑损伤。
本多中心前瞻性队列研究纳入了准备行 CAS 的严重颈动脉狭窄(>70%)患者。于 CAS 前 3 天内测量患者血浆 TMAO 水平,于 CAS 后 1 至 3 天内进行 MRI。
268 例符合条件的患者中,平均年龄为 64.4 岁。117 例患者(43.7%)弥散加权成像(diffusion-weighted imaging,DWI)出现新病灶。与无新发 DWI 病灶的患者相比,有新病灶的患者 TMAO 水平更高(中位数为 5.2μmol/L 比 3.2μmol/L;<0.001)。血浆 TMAO 水平升高与 CAS 后 DWI 出现新病灶的风险增加相关(最高四分位数与最低四分位数相比,调整后的优势比为 3.85;95%置信区间为 1.37-7.56;<0.001;第三四分位数与最低四分位数相比,调整后的优势比为 1.86;95%置信区间为 1.09-4.66;=0.02)。TMAO 预测 DWI 新病灶的受试者工作特征曲线下面积为 0.706,最佳截断值为 4.29μmol/L。TMAO 水平≥4.29μmol/L 预测 DWI 新病灶的敏感性、特异性、阳性预测值和阴性预测值分别为 61.5%、74.8%、65.5%和 65.5%。
TMAO 水平升高与 CAS 后 MRI 新缺血性脑病灶风险增加相关。